Studie zeigt: Sorafenib bei Hepatopulmonalem Syndrom leider unwirksam

aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/lt.25438
Titel: Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double‐Blind, Placebo‐Controlled Trial Steven M. Kawut  
  Susan S. Ellenberg    Michael J. Krowka    David Goldberg    Hugo Vargas    David Koch    Tiffany Sharkoski    Nadine Al‐Naamani    Alyson Fox    Robert Brown    Joshua Levitsky    
First published:28 February 2019

doi.org/10.1002/lt.25438